Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Recruiting now · Not applicable
Conditions studied: Asthma (Diagnosis)
In brief
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Key facts
- Study ID
- NCT07529847
- Run by
- Foundation University Islamabad
- People needed
- 46
- Starts
- 2026-02-28
- Expected to finish
- 2026-05-15
- Last updated by the study team
- 2026-04-14
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 18-45 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)
You may not qualify if…
- Patients having acute exerbation of COPD/status asthmaticus
- Patients diagnosed with acute infection
- Patients unable to follow command and instructions
- Asthma patients with >40sec control pause duration
Where it is running
- Foundation University Islamabad — Islamabad, Pakistan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.